New to Podcasts?
Trials of aliskiren for CAD and otamixaban for NSTE-ACS, chronic care management for substance dependence, and more.

JAMA Editor’s Summary

Trials of aliskiren for CAD and otamixaban for NSTE-ACS, chronic care management for substance dependence, and more.

Trials of aliskiren for CAD and otamixaban for NSTE-ACS, chronic care management for substance dependence, and more.

Editor’s Audio Summary by Phil B. Fontanarosa, MD, MBA, Executive Editor, the Journal of the American Medical Association, for the September 18, 2013 issue

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover Welcome to the Health Podcast Network!
00:00
00:00
volume-low